Therapeutic product, use and formulation thereof

Details for Australian Patent Application No. 2006201923 (hide)

International Classifications

Event Publications

25 May 2006 Application Open to Public Inspection

Published as AU-B-2006201923

25 May 2006 Complete Application Filed

22 May 2008 Application Accepted

Published as AU-B-2006201923

28 August 2008 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 05 Aug 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

25 September 2008 Standard Patent Sealed

22 January 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 05 Aug 2008

2 April 2009 Alteration of Name

The name of the patentee has been altered to MiddleBrook Pharmaceuticals, Inc.

21 April 2011 Assignment Registered

MiddleBrook Pharmaceuticals, Inc. The patent has been assigned to Victory Pharma, Inc.

20 October 2011 Assignment Registered

Victory Pharma, Inc. The patent has been assigned to Shionogi, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.